These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18950384)

  • 1. Unusual weight fluctuation under corticosteroid and psychotropic treatment.
    Terao T
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):617-9. PubMed ID: 18950384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK; McKenzie J; Worrall N
    Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
    Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosis in the elderly.
    Kyomen HH; Whitfield TH
    Am J Psychiatry; 2009 Feb; 166(2):146-50. PubMed ID: 19188291
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delusional disorder, somatic type treated with aripiprazole--mirtazapine combination.
    Dimopoulos NP; Mitsonis CI; Psarra VV
    J Psychopharmacol; 2008 Sep; 22(7):812-4. PubMed ID: 18308798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does aripiprazole protect from serotonin syndrome?
    Rittmannsberger H; Werl R
    Psychiatr Danub; 2012 Mar; 24(1):100-1. PubMed ID: 22447095
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of trichotillomania with aripiprazole.
    Jefferys D; Burrows G
    Depress Anxiety; 2008; 25(6):E37-40. PubMed ID: 17941109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole-induced sialorrhea.
    Praharaj SK; Jana AK; Sinha VK
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):384-5. PubMed ID: 19162120
    [No Abstract]   [Full Text] [Related]  

  • 11. Lower gastrointestinal bleeding and paroxetine use: two case reports.
    Blasco-Fontecilla H; de Leon J
    Psychosomatics; 2012; 53(2):184-7. PubMed ID: 22424167
    [No Abstract]   [Full Text] [Related]  

  • 12. An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
    Menza MA; Dobkin RD; Marin H
    J Clin Psychopharmacol; 2007 Apr; 27(2):207-10. PubMed ID: 17414231
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine in the treatment of resistant depression.
    Caetano D; Caetano SC
    Aust N Z J Psychiatry; 2005; 39(1-2):108-9. PubMed ID: 15660713
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole in refractory depression?
    Carroll BJ
    J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aripiprazole and acute dystonia].
    Komen G; Van Den Eede F; Dom G
    Tijdschr Psychiatr; 2009; 51(10):761-5. PubMed ID: 19821245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive aripiprazole for bupropion-resistant major depression.
    Sokolski KN
    Ann Pharmacother; 2008 Jul; 42(7):1124-9. PubMed ID: 18492784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole-associated acute dystonia.
    Sanghadia M; Pinninti NR
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):89-90. PubMed ID: 17308239
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
    Boulton DW; Balch AH; Royzman K; Patel CG; Berman RM; Mallikaarjun S; Reeves RA
    J Psychopharmacol; 2010 Apr; 24(4):537-46. PubMed ID: 18832427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unclear clinical significance of findings in adjunctive aripiprazole for major depressive disorder: comments on article by Marcus et al.
    Tsai AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):91-2; author reply 92-3. PubMed ID: 19142118
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Adan-Manes J; Garcia-Parajua P
    J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.